Gastroenterology treatment methods and clinical efficacy in elderly type 2 diabetic patients with functional constipation
老年2型糖尿病功能性便秘患者消化内科治疗方法及临床疗效

摘要

目的 探讨老年2型糖尿病功能性便秘患者消化内科治疗方法及临床疗效。方法 选取2020年1月至2020年12月我院收治的老年2型糖尿病功能性便秘患者90例，将其平均分为两组，每组患者人数均为45例。对照组患者采用莫沙必利予以治疗，观察组患者在此基础上采用乳果糖联合双歧杆菌进行治疗，比较这两种方法对老年2型糖尿病功能性便秘患者的临床治疗效果。结果 经过数据分析可以发现，观察组患者的治疗有效率、复发率、不良反应发生率、排便困难评分、每周排便次数和排便不尽评分，与对照组患者的相关数据，均存在着明显的差异，具有统计学意义（P＜0.05）。结论 采用莫沙必利、乳果糖与双歧杆菌三联疗法，可以显著提高老年2型糖尿病功能性便秘患者的整体治疗效果及安全性，使患者的排便功能尽快恢复正常。同时有效降低该种病症的复发率，使患者免受额外的疼痛折磨，值得在今后的临床治疗工作中进一步推广。

Abstract

Objective: T o explore the treatment methods and clinical effects of digestive medicine in elderly patients with type 2 diabetes and functional constipation.
Methods: A total of 90 elderly patients with type 2 diabetes and functional constipation who were admitted to our hospital from January 2020 to December 2020 were divided into two groups, with the number of patients in each group being 45. Patients in the control group were treated with mosapride, and patients in the observation group were treated with lactulose combined with bifidobacteria on this basis. The clinical treatment effects of these two methods on elderly type 2 diabetic patients with functional constipation were compared.
Results: After data analysis, it can be found that the treatment effectiveness, recurrence rate, adverse reaction rate, dysfunction score, number of bowel movements per week, and incomplete defecation scores in the observation group are significantly related to those in the control group. The difference is statistically significant (P<0.05).
Conclusion  : The triple therapy of mosapride, lactulose and bifidobacteria can significantly improve the overall therapeutic effect and safety of elderly type 2 diabetic patients with functional constipation, and make the patients' bowel function return to normal as soon as possible. At the same time, it can effectively reduce the recurrence rate of this kind of disease and protect patients from additional pain. It is worthy of further promotion in future clinical treatment work.